REVIEW article
Front. Microbiol.
Sec. Infectious Agents and Disease
Diagnostic Value and Challenges in the Immune Regulation of Pentraxin 3 in Infectious Diseases
Provisionally accepted
- 1Affiliated Hospital of Hebei University, Baoding, China
- 2Hebei University, Baoding, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Infectious diseases pose a severe threat to human health, and their early and precise diagnosis and intervention remain a major challenge in clinical practice. This review systematically examines the diagnostic value and immunomodulatory role of PTX3 across a spectrum of infectious diseases, including those affecting the respiratory, cardiovascular, digestive, urinary, and nervous systems, as well as orthopedic and skin infections. The aim is to provide novel perspectives for overcoming the bottleneck in precise diagnosis and treatment of infectious diseases. Currently, diagnosis and assessment primarily rely on clinical manifestations, conventional inflammatory markers such as C-reactive protein and procalcitonin, and pathogen detection. However, these methods often have limitations in sensitivity, specificity, and early warning capability, underscoring the need for novel, high-value biomarkers to enhance diagnostic and therapeutic precision. Long pentraxin 3 (PTX3), a key acute-phase reactant protein and soluble pattern recognition receptor, has recently garnered considerable attention for its role in infectious diseases. PTX3 is rapidly synthesized by innate immune and endothelial cells in response to stimulation by pathogens or inflammatory mediators. Functionally, PTX3 contributes to host defense through opsonophagocytosis, complement activation, and modulation of inflammatory responses. Quantification of circulating PTX3 levels demonstrates potential as an adjunctive biomarker for the diagnosis of infectious diseases and holds considerable value in early risk stratification, precise disease assessment, and personalized therapeutic strategies. Nevertheless, the clinical application of PTX3 faces two major challenges in immune regulation. Its broad-spectrum responsiveness to inflammation limits its specificity in pathogen differentiation, and the mechanisms underlying its immunomodulatory activity remain complex. This review systematically summarizes recent advances in the diagnostic significance and immunoregulatory mechanisms of PTX3, providing new insights into overcoming current challenges in the precision diagnosis and treatment of infectious diseases.
Keywords: biomarker, Immune Regulation, infectious diseases, Inflammatory Response, PTX3
Received: 29 Dec 2025; Accepted: 05 Feb 2026.
Copyright: © 2026 Shao, Li, Zhang, Lv, Li, Cui and Sheng. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Na Cui
Ping Sheng
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.